GB201005204D0 - Improvements in heterotypic formulations of anticancer drugs - Google Patents
Improvements in heterotypic formulations of anticancer drugsInfo
- Publication number
- GB201005204D0 GB201005204D0 GBGB1005204.1A GB201005204A GB201005204D0 GB 201005204 D0 GB201005204 D0 GB 201005204D0 GB 201005204 A GB201005204 A GB 201005204A GB 201005204 D0 GB201005204 D0 GB 201005204D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- heterotypic
- formulations
- anticancer drugs
- anticancer
- drugs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1001959.4A GB201001959D0 (en) | 2010-02-06 | 2010-02-06 | Formulations of generic drugs against cancer and infectious diseases |
| GBGB1004712.4A GB201004712D0 (en) | 2010-02-06 | 2010-03-22 | Improvements in the chemotherapy of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201005204D0 true GB201005204D0 (en) | 2010-05-12 |
Family
ID=42082589
Family Applications (17)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1001959.4A Ceased GB201001959D0 (en) | 2010-02-06 | 2010-02-06 | Formulations of generic drugs against cancer and infectious diseases |
| GBGB1002941.1A Ceased GB201002941D0 (en) | 2010-02-06 | 2010-02-22 | Delaying the development of resistances to anticancer,antibacterial and some other drugs |
| GBGB1003116.9A Ceased GB201003116D0 (en) | 2010-02-06 | 2010-02-24 | Reversing resistance to anticancer, antibacterial and some other drugs |
| GBGB1003119.3A Ceased GB201003119D0 (en) | 2010-02-06 | 2010-02-24 | Methods for delaying or overcoming bacterial drug resistance to beta-lactam and other antibiotics |
| GBGB1003514.5A Ceased GB201003514D0 (en) | 2010-02-06 | 2010-03-03 | Improvements in antibacterial drugs |
| GBGB1003509.5A Ceased GB201003509D0 (en) | 2010-02-06 | 2010-03-03 | Delaying the development of resistances to anticancer,antibacterial and some other drugs |
| GBGB1003676.2A Ceased GB201003676D0 (en) | 2010-02-06 | 2010-03-05 | Overcoming beta-lactam drug resistance |
| GBGB1003782.8A Ceased GB201003782D0 (en) | 2010-02-06 | 2010-03-08 | A wide-spectrum chemotherapy of cancers and baterial diseases |
| GBGB1003935.2A Ceased GB201003935D0 (en) | 2010-02-06 | 2010-03-10 | Improvements in antibacterial drugs |
| GBGB1004209.1A Ceased GB201004209D0 (en) | 2010-02-06 | 2010-03-15 | Low toxic 5-fluorouracil chemotherapy |
| GBGB1004328.9A Ceased GB201004328D0 (en) | 2010-02-06 | 2010-03-16 | Increasing the efficacy of anticancer drugs |
| GBGB1004415.4A Ceased GB201004415D0 (en) | 2010-02-06 | 2010-03-17 | Increasing the selectivity of the anticancer drug cyclophamide |
| GBGB1004712.4A Ceased GB201004712D0 (en) | 2010-02-06 | 2010-03-22 | Improvements in the chemotherapy of cancer |
| GBGB1004714.0A Ceased GB201004714D0 (en) | 2010-02-06 | 2010-03-22 | Chemotherapy of cancer and infectious diseases |
| GBGB1005204.1A Ceased GB201005204D0 (en) | 2010-02-06 | 2010-03-29 | Improvements in heterotypic formulations of anticancer drugs |
| GBGB1013592.9A Ceased GB201013592D0 (en) | 2010-02-06 | 2010-08-13 | Prophylactic preparations against sexually transmitted diseases |
| GBGB1013699.2A Ceased GB201013699D0 (en) | 2010-02-06 | 2010-08-16 | Methods for overcoming antibacterial drug resistance |
Family Applications Before (14)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1001959.4A Ceased GB201001959D0 (en) | 2010-02-06 | 2010-02-06 | Formulations of generic drugs against cancer and infectious diseases |
| GBGB1002941.1A Ceased GB201002941D0 (en) | 2010-02-06 | 2010-02-22 | Delaying the development of resistances to anticancer,antibacterial and some other drugs |
| GBGB1003116.9A Ceased GB201003116D0 (en) | 2010-02-06 | 2010-02-24 | Reversing resistance to anticancer, antibacterial and some other drugs |
| GBGB1003119.3A Ceased GB201003119D0 (en) | 2010-02-06 | 2010-02-24 | Methods for delaying or overcoming bacterial drug resistance to beta-lactam and other antibiotics |
| GBGB1003514.5A Ceased GB201003514D0 (en) | 2010-02-06 | 2010-03-03 | Improvements in antibacterial drugs |
| GBGB1003509.5A Ceased GB201003509D0 (en) | 2010-02-06 | 2010-03-03 | Delaying the development of resistances to anticancer,antibacterial and some other drugs |
| GBGB1003676.2A Ceased GB201003676D0 (en) | 2010-02-06 | 2010-03-05 | Overcoming beta-lactam drug resistance |
| GBGB1003782.8A Ceased GB201003782D0 (en) | 2010-02-06 | 2010-03-08 | A wide-spectrum chemotherapy of cancers and baterial diseases |
| GBGB1003935.2A Ceased GB201003935D0 (en) | 2010-02-06 | 2010-03-10 | Improvements in antibacterial drugs |
| GBGB1004209.1A Ceased GB201004209D0 (en) | 2010-02-06 | 2010-03-15 | Low toxic 5-fluorouracil chemotherapy |
| GBGB1004328.9A Ceased GB201004328D0 (en) | 2010-02-06 | 2010-03-16 | Increasing the efficacy of anticancer drugs |
| GBGB1004415.4A Ceased GB201004415D0 (en) | 2010-02-06 | 2010-03-17 | Increasing the selectivity of the anticancer drug cyclophamide |
| GBGB1004712.4A Ceased GB201004712D0 (en) | 2010-02-06 | 2010-03-22 | Improvements in the chemotherapy of cancer |
| GBGB1004714.0A Ceased GB201004714D0 (en) | 2010-02-06 | 2010-03-22 | Chemotherapy of cancer and infectious diseases |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1013592.9A Ceased GB201013592D0 (en) | 2010-02-06 | 2010-08-13 | Prophylactic preparations against sexually transmitted diseases |
| GBGB1013699.2A Ceased GB201013699D0 (en) | 2010-02-06 | 2010-08-16 | Methods for overcoming antibacterial drug resistance |
Country Status (1)
| Country | Link |
|---|---|
| GB (17) | GB201001959D0 (en) |
-
2010
- 2010-02-06 GB GBGB1001959.4A patent/GB201001959D0/en not_active Ceased
- 2010-02-22 GB GBGB1002941.1A patent/GB201002941D0/en not_active Ceased
- 2010-02-24 GB GBGB1003116.9A patent/GB201003116D0/en not_active Ceased
- 2010-02-24 GB GBGB1003119.3A patent/GB201003119D0/en not_active Ceased
- 2010-03-03 GB GBGB1003514.5A patent/GB201003514D0/en not_active Ceased
- 2010-03-03 GB GBGB1003509.5A patent/GB201003509D0/en not_active Ceased
- 2010-03-05 GB GBGB1003676.2A patent/GB201003676D0/en not_active Ceased
- 2010-03-08 GB GBGB1003782.8A patent/GB201003782D0/en not_active Ceased
- 2010-03-10 GB GBGB1003935.2A patent/GB201003935D0/en not_active Ceased
- 2010-03-15 GB GBGB1004209.1A patent/GB201004209D0/en not_active Ceased
- 2010-03-16 GB GBGB1004328.9A patent/GB201004328D0/en not_active Ceased
- 2010-03-17 GB GBGB1004415.4A patent/GB201004415D0/en not_active Ceased
- 2010-03-22 GB GBGB1004712.4A patent/GB201004712D0/en not_active Ceased
- 2010-03-22 GB GBGB1004714.0A patent/GB201004714D0/en not_active Ceased
- 2010-03-29 GB GBGB1005204.1A patent/GB201005204D0/en not_active Ceased
- 2010-08-13 GB GBGB1013592.9A patent/GB201013592D0/en not_active Ceased
- 2010-08-16 GB GBGB1013699.2A patent/GB201013699D0/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| GB201004712D0 (en) | 2010-05-05 |
| GB201003676D0 (en) | 2010-04-21 |
| GB201001959D0 (en) | 2010-03-24 |
| GB201013592D0 (en) | 2010-09-29 |
| GB201004328D0 (en) | 2010-04-28 |
| GB201004415D0 (en) | 2010-05-05 |
| GB201003514D0 (en) | 2010-04-21 |
| GB201003119D0 (en) | 2010-04-14 |
| GB201013699D0 (en) | 2010-09-29 |
| GB201003935D0 (en) | 2010-05-12 |
| GB201004209D0 (en) | 2010-04-28 |
| GB201002941D0 (en) | 2010-04-07 |
| GB201003116D0 (en) | 2010-04-14 |
| GB201004714D0 (en) | 2010-05-05 |
| GB201003782D0 (en) | 2010-04-21 |
| GB201003509D0 (en) | 2010-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2643045A4 (en) | Therapeutic methods and compositions for solid delivery | |
| ZA201300458B (en) | C-met-modulator pharmaceutical compositions | |
| ZA201301766B (en) | Pharmaceutical compositions | |
| GB201104473D0 (en) | Improved pharmaceutical compositions and methods of delivery | |
| EP2629786A4 (en) | Compositions for drug administration | |
| ZA201300718B (en) | Pharmaceutical compositions | |
| ZA201207670B (en) | Pharmaceutical compositions | |
| GB2486567B (en) | Pharmaceutical formulation | |
| ZA201302012B (en) | Low dose pharmaceutical composition | |
| IL226554A (en) | Pharmaceutical compositions comprising alisporivir | |
| IL221087A (en) | Pharmaceutical or neutraceutical formulation | |
| SG10201508982TA (en) | Pharmaceutical compositions | |
| IL221501A (en) | Pharmaceutical composition comprising myramistin | |
| EP2560678A4 (en) | Pharmaceutical compositions | |
| GB201005204D0 (en) | Improvements in heterotypic formulations of anticancer drugs | |
| EP2668961A4 (en) | Combined pharmaceutical preparation | |
| GB0811684D0 (en) | Improvements in heterotypic formulations of anticancer drugs | |
| GB201005639D0 (en) | Drug delivery formulations | |
| GB201012047D0 (en) | Pharmaceutical formulations | |
| GB201012046D0 (en) | Pharmaceutical formulations | |
| GB0716743D0 (en) | Improvements in heterotypic formulations of anticancer drugs | |
| PL390434A1 (en) | Medicinal preparation | |
| PL390620A1 (en) | Pharmaceutical preparation | |
| IL226378A0 (en) | Pharmaceutical compositions | |
| GB201008590D0 (en) | Pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |